# Equillium Stock Fundamentals

EQ Stock | USD 1.85 0.08 4.52% |

Equillium fundamentals help investors to digest information that contributes to Equillium's financial success or failures. It also enables traders to predict the movement of Equillium Stock. The fundamental analysis module provides a way to measure Equillium's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Equillium stock.

At this time, Equillium's Interest Income is relatively stable compared to the past year. As of 04/17/2024, Interest Expense is likely to grow to about 748.9 **K**, while Net Loss is likely to drop (8.6

**M**).

Equillium | Select Account or Indicator |

## Equillium Company Operating Margin Analysis

Equillium's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

## Current Equillium Operating Margin | (0.35) % |

Most of Equillium's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Equillium is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.

Competition |

Based on the recorded statements, Equillium has an Operating Margin of -0.3474%. This is 99.01% lower than that of the Biotechnology sector and 99.69% lower than that of the Health Care industry. The operating margin for all United States stocks is 93.7% lower than that of the firm.

## Equillium Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Equillium's current stock value. Our valuation model uses many indicators to compare Equillium value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Equillium competition to find correlations between indicators driving Equillium's intrinsic value. More Info.Equillium is rated**below average**in return on equity category among related companies. It is rated

**# 2**in return on asset category among related companies . At this time, Equillium's Return On Equity is relatively stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Equillium by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Equillium's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Equillium's earnings, one of the primary drivers of an investment's value.

## Equillium Operating Margin Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Equillium's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Equillium could also be used in its relative valuation, which is a method of valuing Equillium by comparing valuation metrics of similar companies.Equillium is currently under evaluation in operating margin category among related companies.

## Equillium Current Valuation Drivers

We derive many important indicators used in calculating different scores of Equillium from analyzing Equillium's financial statements. These drivers represent accounts that assess Equillium's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Equillium's important valuation drivers and their relationship over time.

2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||

Market Cap | 58.7M | 108.9M | 108.6M | 35.8M | 25.1M | 23.9M | |

Enterprise Value | 55.2M | 93.2M | 68.2M | (13.2M) | 2.7M | 2.6M |

## Equillium Fundamentals

Return On Equity | -0.49 | ||||

Return On Asset | -0.14 | ||||

Profit Margin | (0.37) % | ||||

Operating Margin | (0.35) % | ||||

Current Valuation | 25.18 M | ||||

Shares Outstanding | 35.25 M | ||||

Shares Owned By Insiders | 36.42 % | ||||

Shares Owned By Institutions | 21.65 % | ||||

Number Of Shares Shorted | 394.47 K | ||||

Price To Earning | (6.70) X | ||||

Price To Book | 2.95 X | ||||

Price To Sales | 1.81 X | ||||

Revenue | 36.08 M | ||||

Gross Profit | 15.76 M | ||||

EBITDA | (14.4 M) | ||||

Net Income | (13.34 M) | ||||

Cash And Equivalents | 57.56 M | ||||

Cash Per Share | 1.68 X | ||||

Total Debt | 824 K | ||||

Debt To Equity | 0.29 % | ||||

Current Ratio | 3.98 X | ||||

Book Value Per Share | 0.64 X | ||||

Cash Flow From Operations | (21.78 M) | ||||

Short Ratio | 1.53 X | ||||

Earnings Per Share | (0.38) X | ||||

Target Price | 7.0 | ||||

Number Of Employees | 44 | ||||

Beta | 1.67 | ||||

Market Capitalization | 65.22 M | ||||

Total Asset | 50.53 M | ||||

Retained Earnings | (185.74 M) | ||||

Working Capital | 21.78 M | ||||

Current Asset | 60.04 M | ||||

Current Liabilities | 1.81 M | ||||

Net Asset | 50.53 M |

## About Equillium Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Equillium's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Equillium using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Equillium based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.Last Reported | Projected for Next Year | ||

Current Deferred Revenue | 15.7 M | 16.7 M | |

Total Revenue | 36.1 M | 37.9 M | |

Cost Of Revenue | 126 K | 132.3 K | |

Stock Based Compensation To Revenue | 0.11 | 0.11 | |

Sales General And Administrative To Revenue | 0.38 | 0.36 | |

Research And Ddevelopement To Revenue | 1.03 | 1.87 | |

Capex To Revenue | (0) | (0) | |

Revenue Per Share | 1.04 | 0.60 | |

Ebit Per Revenue | (0.40) | (0.42) |

## Pair Trading with Equillium

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Equillium position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Equillium will appreciate offsetting losses from the drop in the long position's value.### Moving together with Equillium Stock

0.76 | ERAS | Erasca Inc Financial Report 20th of May 2024 | PairCorr |

0.63 | BMY | Bristol Myers Squibb Financial Report 25th of April 2024 | PairCorr |

### Moving against Equillium Stock

0.81 | AMGN | Amgen Inc Financial Report 25th of April 2024 | PairCorr |

0.71 | BIIB | Biogen Inc Earnings Call This Week | PairCorr |

0.64 | ABVC | ABVC Biopharma | PairCorr |

0.51 | VRTX | Vertex Pharmaceuticals Financial Report 6th of May 2024 | PairCorr |

The ability to find closely correlated positions to Equillium could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Equillium when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Equillium - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Equillium to buy it.

The correlation of Equillium is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Equillium moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Equillium moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Equillium can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.**Highlighted below are key reports to facilitate an investment decision about Equillium Stock:**

Check out Equillium Piotroski F Score and Equillium Altman Z Score analysis. To learn how to invest in Equillium Stock, please use our How to Invest in Equillium guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

## Complementary Tools for Equillium Stock analysis

When running Equillium's price analysis, check to measure Equillium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Equillium is operating at the current time. Most of Equillium's value examination focuses on studying past and present price action to predict the probability of Equillium's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Equillium's price. Additionally, you may evaluate how the addition of Equillium to your portfolios can decrease your overall portfolio volatility.

Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |

Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |

Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |

Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |

Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |

Equity Valuation Check real value of public entities based on technical and fundamental data | |

Content Syndication Quickly integrate customizable finance content to your own investment portal | |

Analyst Advice Analyst recommendations and target price estimates broken down by several categories |

Is Equillium's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Equillium. If investors know Equillium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Equillium listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share(0.38) | Revenue Per Share1.039 | Quarterly Revenue Growth(0.42) | Return On Assets(0.14) | Return On Equity(0.49) |

The market value of Equillium is measured differently than its book value, which is the value of Equillium that is recorded on the company's balance sheet. Investors also form their own opinion of Equillium's value that differs from its market value or its book value, called intrinsic value, which is Equillium's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Equillium's market value can be influenced by many factors that don't directly affect Equillium's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Equillium's value and its price as these two are different measures arrived at by different means. Investors typically determine if Equillium is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Equillium's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.